Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults

[1]  Christos Davatzikos,et al.  Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases , 2018, NeuroImage.

[2]  C. Jack,et al.  Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study , 2017, The Lancet Neurology.

[3]  A. Rahmim,et al.  Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.

[4]  Christos Davatzikos,et al.  MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection , 2016, NeuroImage.

[5]  J. Schneider,et al.  Vascular contributions to cognitive impairment and dementia including Alzheimer's disease , 2015, Alzheimer's & Dementia.

[6]  Susan M. Resnick,et al.  Greater cortical thinning in normal older adults predicts later cognitive impairment , 2015, Neurobiology of Aging.

[7]  Orla Hardiman,et al.  Presymptomatic and longitudinal neuroimaging in neurodegeneration—from snapshots to motion picture: a systematic review , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  Rena Li,et al.  Sex differences in cognitive impairment and Alzheimer’s disease , 2014, Frontiers in Neuroendocrinology.

[9]  A. Dale,et al.  Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease , 2013, The Journal of Neuroscience.

[10]  B. Dickerson,et al.  MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults , 2012, Neurology.

[11]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[12]  C. DeCarli,et al.  Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline , 2011, Alzheimer's & Dementia.

[13]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[14]  Ulman Lindenberger,et al.  Trajectories of brain aging in middle-aged and older adults: Regional and individual differences , 2010, NeuroImage.

[15]  C. Jack,et al.  MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.

[16]  J. Molinuevo,et al.  Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease , 2009, Neurobiology of Aging.

[17]  S. Rubin,et al.  Predictors of maintaining cognitive function in older adults , 2009, Neurology.

[18]  S. Resnick,et al.  Longitudinal pattern of regional brain volume change differentiates normal aging from MCI , 2009, Neurology.

[19]  M. Weiner,et al.  Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease* , 2009, Brain : a journal of neurology.

[20]  Olga Pletnikova,et al.  Effect of infarcts on dementia in the Baltimore longitudinal study of aging , 2008, Annals of neurology.

[21]  F. Pasquier,et al.  Risk profiles for mild cognitive impairment and progression to dementia are gender specific , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  O. Hanon,et al.  Vascular risk factors, cognitve decline, and dementia , 2008, Vascular health and risk management.

[23]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[24]  C. Jack,et al.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.

[25]  C. Jack,et al.  Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.

[26]  F. Panza,et al.  Lipid metabolism in cognitive decline and dementia , 2006, Brain Research Reviews.

[27]  P. Scheltens,et al.  Age, Hypertension, and Lacunar Stroke Are the Major Determinants of the Severity of Age-Related White Matter Changes , 2006, Cerebrovascular Diseases.

[28]  Charles DeCarli,et al.  Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .

[29]  Nick C. Fox,et al.  Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.

[30]  Karen M Rodrigue,et al.  Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. , 2003, Behavioral neuroscience.

[31]  S. Resnick,et al.  Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain , 2003, The Journal of Neuroscience.

[32]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[33]  R Brookmeyer,et al.  Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.

[34]  K. Hall,et al.  Serum cholesterol, APOE genotype, and the risk of Alzheimer’s disease: A population-based study of African Americans , 2000, Neurology.

[35]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[36]  D. Grossi,et al.  Plasma lipids and geriatric assessment in a very aged population of south Italy. , 1989, Atherosclerosis.

[37]  S. Bellur.  Alzheimer's Disease: Senile Dementia and Related Disorders , 1979 .

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.